Jane Street Group, LLC Iveric Bio, Inc. Call Options Transaction History

Jane Street Group, LLC

  • $445 Billion
  • Q3 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 17, 2022
BUY
$12.15 - $16.83 $2.65 Million - $3.67 Million
218,100 Added 566.49%
256,600 $4.32 Million
Q4 2021

Feb 15, 2022
SELL
$13.83 - $18.78 $2.2 Million - $2.99 Million
-159,400 Reduced 80.55%
38,500 $644,000
Q3 2021

Nov 16, 2021
BUY
$7.07 - $17.5 $1.4 Million - $3.46 Million
197,900 New
197,900 $3.21 Million

Others Institutions Holding ISEE

# of Institutions
7
Shares Held
250K
Call Options Held
40K
Put Options Held
0
View Full List

About IVERIC bio, Inc.

ISEE Quotes by TradingView
  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email